These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical pharmacokinetics in infants and children. A reappraisal. Kearns GL; Reed MD Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939 [TBL] [Abstract][Full Text] [Related]
23. [Pharmacogenetics: relevant aspects for the practicing veterinarian]. Jud Schefer R; Paine Kuhn C; Demuth D Schweiz Arch Tierheilkd; 2012 Dec; 154(12):521-7. PubMed ID: 23188764 [TBL] [Abstract][Full Text] [Related]
24. Plasma paroxonase activity in old age. Playfer JR; Powell C; Evans DA Age Ageing; 1977 May; 6(2):89-95. PubMed ID: 888750 [TBL] [Abstract][Full Text] [Related]
25. Pediatric pharmacology in the first year of life. Sumpter A; Anderson BJ Curr Opin Anaesthesiol; 2009 Aug; 22(4):469-75. PubMed ID: 19593898 [TBL] [Abstract][Full Text] [Related]
26. [Clinical aspects of drug interactions. Mechanisms of interactions]. Prandota J; Witkowska M Postepy Hig Med Dosw; 1976; 30(4):493-514. PubMed ID: 1005259 [No Abstract] [Full Text] [Related]
27. Pharmacogenetics: multiple interactions between genes and environment as determinants of drug response. Vesell ES Am J Med; 1979 Feb; 66(2):183-7. PubMed ID: 425962 [No Abstract] [Full Text] [Related]
29. Ontogeny of Pediatric Pharmacogenetics: Celebrating the Past and Vision for the Future. Leeder JS J Pediatr Pharmacol Ther; 2022; 27(1):4-11. PubMed ID: 35002553 [No Abstract] [Full Text] [Related]
30. LPS-Induced Inflammation Affects Midazolam Clearance in Juvenile Mice in an Age-Dependent Manner. Zheng Y; Ye PP; Zhou Y; Wu SY; Liu XT; Du B; Tang BH; Kan M; Nie AQ; Yin R; Wang M; Hao GX; Song LL; Yang XM; Huang X; Su LQ; Wang WQ; van den Anker J; Zhao W J Inflamm Res; 2021; 14():3697-3706. PubMed ID: 34377007 [TBL] [Abstract][Full Text] [Related]
31. A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing Vehicles. Wollmer E; Karkossa F; Freerks L; Hetberg AE; Neal G; Porter J; Whitaker MJ; Margetson D; Klein S Pharm Res; 2020 Sep; 37(10):203. PubMed ID: 32968894 [TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure. Sergi CM Front Pharmacol; 2019; 10():1563. PubMed ID: 32063842 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder. Upadhyaya H; Kratochvil C; Ghuman J; Camporeale A; Lipsius S; D'Souza D; Tanaka Y J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):799-809. PubMed ID: 25265343 [TBL] [Abstract][Full Text] [Related]
34. Atomoxetine: a novel treatment for child and adult ADHD. Ledbetter M Neuropsychiatr Dis Treat; 2006 Dec; 2(4):455-66. PubMed ID: 19412494 [TBL] [Abstract][Full Text] [Related]
35. Future pharmacologic agents for treatment of heart failure in children. Moffett BS; Chang AC Pediatr Cardiol; 2006; 27(5):533-51. PubMed ID: 16933064 [TBL] [Abstract][Full Text] [Related]
36. Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Ganiere-Monteil C; Medard Y; Lejus C; Bruneau B; Pineau A; Fenneteau O; Bourin M; Jacqz-Aigrain E Eur J Clin Pharmacol; 2004 Apr; 60(2):89-96. PubMed ID: 15022030 [TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment. Gold BD; Freston JW Paediatr Drugs; 2002; 4(10):673-85. PubMed ID: 12269842 [TBL] [Abstract][Full Text] [Related]
38. Cytochrome P450 3A: ontogeny and drug disposition. de Wildt SN; Kearns GL; Leeder JS; van den Anker JN Clin Pharmacokinet; 1999 Dec; 37(6):485-505. PubMed ID: 10628899 [TBL] [Abstract][Full Text] [Related]